Cervical cancer ranks as the fourth most prevalent cancer in women, with around 604,127 cases and 341,831 deaths globally in 2020. In Indonesia, the mortality rate reached 57% in 2021. As it is caused by high-risk HPV infection, cervical cancer can be prevented through early detection of HPV and vaccination against the virus. We are dedicated to lowering cervical cancer incidence rates. Our product lineup is designed to deliver swift and precise diagnosis, empowering healthcare providers to make informed clinical decisions for their patients.